- Home
- SBCF vs SWTX Comparison
SBCF vs SWTX Comparison
Compare SBCF & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBCF
- SWTX
- Stock Information
- Founded
- SBCF 1926
- SWTX 2017
- Country
- SBCF United States
- SWTX United States
- Employees
- SBCF N/A
- SWTX N/A
- Industry
- SBCF Major Banks
- SWTX Biotechnology: Pharmaceutical Preparations
- Sector
- SBCF Finance
- SWTX Health Care
- Exchange
- SBCF Nasdaq
- SWTX Nasdaq
- Market Cap
- SBCF 2.5B
- SWTX 2.2B
- IPO Year
- SBCF N/A
- SWTX 2019
- Fundamental
- Price
- SBCF $28.22
- SWTX $37.72
- Analyst Decision
- SBCF Hold
- SWTX Strong Buy
- Analyst Count
- SBCF 5
- SWTX 5
- Target Price
- SBCF $28.10
- SWTX $67.00
- AVG Volume (30 Days)
- SBCF 327.9K
- SWTX 1.1M
- Earning Date
- SBCF 01-23-2025
- SWTX 11-12-2024
- Dividend Yield
- SBCF 2.55%
- SWTX N/A
- EPS Growth
- SBCF 10.93
- SWTX N/A
- EPS
- SBCF 1.36
- SWTX N/A
- Revenue
- SBCF $494,135,000.00
- SWTX $135,487,000.00
- Revenue This Year
- SBCF N/A
- SWTX $3,426.90
- Revenue Next Year
- SBCF $8.20
- SWTX $88.92
- P/E Ratio
- SBCF $20.76
- SWTX N/A
- Revenue Growth
- SBCF N/A
- SWTX N/A
- 52 Week Low
- SBCF $21.90
- SWTX $28.21
- 52 Week High
- SBCF $31.68
- SWTX $53.92
- Technical
- Relative Strength Index (RSI)
- SBCF 39.69
- SWTX 46.67
- Support Level
- SBCF $28.53
- SWTX $37.26
- Resistance Level
- SBCF $30.21
- SWTX $42.51
- Average True Range (ATR)
- SBCF 0.68
- SWTX 1.64
- MACD
- SBCF -0.26
- SWTX -0.72
- Stochastic Oscillator
- SBCF 1.17
- SWTX 6.01
About SBCF Seacoast Banking Corporation of Florida
Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The Company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage, and credit facilities.
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.